X0306 4 2022-01-19 false 0001689813 Biohaven Pharmaceutical Holding Co Ltd. BHVN 0001878290 Clark George C. C/O BIOHAVEN PHARMACEUTICALS, INC. 215 CHURCH STREET NEW HAVEN CT 06510 false true false false VP, Chief Accounting Officer Common Shares 2022-01-19 4 M false 3750.00 53.76 A 13470.00 D Common Shares 2022-01-19 4 M false 1920.00 32.42 A 15390.00 D Common Shares 2022-01-19 4 S false 3196.00 114.9293 D 12194.00 D Common Shares 2022-01-19 4 S false 2159.00 116.0189 D 10035.00 D Common Shares 2022-01-19 4 S false 500.00 118.048 D 9535.00 D Common Shares 2022-01-19 4 S false 3520.00 119.3694 D 6015.00 D Employee Stock Option (right to buy) 53.76 2022-01-19 4 M false 3750.00 0.00 D 2029-12-05 Common Shares 3750.00 4500.00 D Employee Stock Option (right to buy) 32.42 2022-01-19 4 M false 1920.00 0.00 D 2028-11-20 Common Shares 1920.00 2875.00 D These exercises and sales were made pursuant to a 10b5-1 trading plan adopted by the Reporting Person. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $114.30 - $115.26, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $115.39 - $116.39, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $117.55 - $118.38, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $118.84 - $119.77, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4. The shares underlying this option vest in four equal installments on December 5, 2019, 2020, 2021 and 2022, subject to the reporting person's continued service with the issuer at each vesting date. The shares underlying this option vest in four equal installments on November 20, 2019, 2020, 2021 and 2022, subject to the reporting person's continued service with the issuer at each vesting date. /s/ George Clark 2022-01-24